Studies suggest that cancer cells exhibit a unique behavior in lipid metabolism; for example, while most normal mature cells acquire FAs from the bloodstream, neoplasm cells exhibit increased de novo FA biosynthesis, most of which is modulated by sterol regulatory element-binding protein 1 (SREBP1) [17,18]. Here, SREBF1 is linked to neoplasm.